Important Safety Information
Stanozolol is a 17α-alkylated anabolic steroid, a structural class associated with significant hepatotoxicity. The FDA label includes a boxed warning for peliosis hepatitis, a condition in which liver and sometimes splenic tissue is replaced with blood-filled cysts. These cysts are sometimes present with minimal hepatic dysfunction but have been associated with liver failure and intra-abdominal hemorrhage .
Stanozolol is contraindicated in pregnancy (Category X), known or suspected carcinoma of the prostate or male breast, carcinoma of the breast in females with hypercalcemia, nephrosis, and severe hepatic dysfunction .
Important
Non-Medical Use
Non-medical use of stanozolol falls outside approved indications. Product purity does not establish that non-medical use is safe or appropriate for an individual.
Potential Adverse Effects
Boxed warnings include liver cell tumors (most often benign and androgen-dependent, but fatal malignant tumors have been reported) and blood lipid changes including decreased HDL and sometimes increased LDL, which may have a serious impact on atherosclerosis and coronary artery disease risk .
Other adverse effects include virilization in women (deepening of voice, hirsutism, acne, clitoral enlargement, menstrual irregularities) which may be irreversible, and premature closure of epiphyses in children . Suppression of endogenous testosterone production may lead to testicular atrophy and reduced fertility.
Conditions Requiring Medical Evaluation
Stanozolol is not appropriate for everyone. Contraindications include pregnancy, prostate cancer, male breast cancer, nephrosis, and severe hepatic dysfunction . Caution is advised in patients with cardiovascular disease, diabetes, or edema .
Geriatric patients treated with androgens may be at increased risk of developing prostatic hypertrophy .
Monitoring During Therapy
Clinical monitoring recommendations include periodic liver function tests, serum lipids, and hemoglobin/hematocrit. Patients should report signs of liver problems including dark urine, tiredness, decreased appetite, upset stomach, stomach pain, vomiting, or yellowing of the skin or eyes.
Product Care
Storage & Handling
Store tablets in a cool, dry place in the original packaging. Keep out of reach of children. Inspect tablets before use and do not use if they appear damaged or compromised.